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726Objective: Cardiac surgery is a major cause of acute kidney injury. In this setting, receipt of blood transfusions
seems to be associated with a higher risk of acute kidney injury, as measured using serum creatinine values. We
examined this association further by using urinary biomarkers of kidney injury.
Methods: A total of 1210 adults underwent cardiac surgery and were divided into 3 groups on the basis of the
receipt of intraoperative packed red blood cell units: no blood (n ¼ 894), 2 or less packed red blood cell units
(n ¼ 206), and more than 2 packed red blood cell units (n ¼ 110). Acute kidney injury was defined as (1)
doubling of serum creatinine from the preoperative value; (2) first postoperative urinary interleukin-18 in the
fifth quintile; and (3) first postoperative urinary neutrophil gelatinase-associated lipocalin in the fifth quintile.
We determined the relative risk for acute kidney injury outcome according to packed red blood cell units group
after adjusting for 12 preoperative and surgical variables. By using the Sobel test for mediation analysis, we also
evaluated the role of biomarkers in causing acute kidney injury through alternative pathways.
Results:Acute kidney injury was more common in those who received more than 2 packed red blood cell units. In
patients receiving more than 2 packed red blood cell units, the adjusted relative risks were 2.3 (95% confidence
interval, 1.2-4.4,P .01), 1.36 (95% confidence interval, 1.0-1.9,P .05), and 1.34 (95% confidence interval, 1.0-1.8,
P.06) for doubling of serum creatinine, urinary interleukin-18 in the fifth quintile (>60 pg/mL), and urinary neutro-
phil gelatinase-associated lipocalin in the fifth quintile (>102 ng/mL), respectively. Furthermore, the effect of
packed red blood cell units transfusion on acute kidney injury was partially mediated by interleukin-18.
Conclusions:Receipt of 2 or more packed red blood cell units during cardiac surgery is associated with a greater
risk of acute kidney injury defined by serum creatinine and kidney injury biomarkers. (J Thorac Cardiovasc Surg
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The Journal of Thoracic and Cardiovascular Surgcare.1-3 It is estimated that more than 1.25 million cardiac
surgeries are performed annually worldwide.4 Given the
large number of cardiothoracic surgeries and associated
AKI, it is necessary to understand potentially modifiable
risk factors for cardiothoracic surgeries and associated AKI.
Acute blood loss or decrease in hematocrit (HCT)
because of hemodilution is common in cardiac surgery;
thus, blood transfusion is frequently performed during
surgery to improve oxygen delivery to kidneys and other
vital organs with the assumption that it will prevent
ischemic injury. However, blood transfusion is not a benign
intervention and has been shown to be associated with mul-
tiorgan failure, including AKI in patients undergoing car-
diopulmonary bypass (CPB).5,6 Because blood transfusion
is a potentially modifiable factor in cardiothoracic
surgeries and associated AKI, the association between
blood transfusion and outcomes in cardiac surgery has
been widely investigated. More recently, data from a
randomized controlled trial suggested that a restrictive
protocol of blood transfusion was not inferior to a liberal
protocol in patients undergoing cardiac surgery.7 To date,
however, most studies investigating the relationship be-
tween blood transfusion and AKI have used creatinine or
dialysis as measures of AKI. Serum creatinine is notery c August 2014
Abbreviations and Acronyms
AKI ¼ acute kidney injury
CABG ¼ coronary artery bypass grafting
CI ¼ confidence interval
CPB ¼ cardiopulmonary bypass
eGFR ¼ estimated glomerular filtration rate
HCT ¼ hematocrit
IL ¼ interleukin
NGAL ¼ neutrophil gelatinase-associated
lipocalin
PRBC ¼ packed red blood cell
RBC ¼ red blood cell
RR ¼ relative risk
TRIBE-AKI ¼ Translational Research Investigating
Biomarker Endpoints in AKI
Khan et al Perioperative Managementconsidered a robust marker for timely diagnosis in AKI
because of the effect of several nonrenal factors, such as
fluids, drugs, and muscle metabolism, on serum creatinine
levels. In addition, creatinine is a functional marker of renal
clearance rather than direct injury. However, there are some
novel urine proteins, neutrophil gelatinase-associated lipo-
calin (NGAL) and interleukin (IL)-18, that are associated
with ischemia reperfusion injury in the kidney and have
demonstrated improved sensitivity for AKI diagnosis
when compared with serum creatinine.8 In addition, animal
studies have demonstrated that NGAL and IL-18 are not
only early biomarkers but also mediators of AKI and
contribute to apoptosis and necrosis of renal tubular cells.9
Because the association between packed red blood cell
(PRBC) transfusion and AKI has been examined by using
serum creatinine, the objective of the present study was to
determine the degree of functional and structural injury
associated with transfusion of PRBCs and to determine
whether urinary biomarkers of kidney injury mediate clin-
ical AKI in this setting.P
MMETHODS
Study Population
We performed a prospective analysis of the adult patient population who
underwent coronary artery bypass grafting (CABG) or valve surgery at 6
academic medical centers in North America between July 2007 and
December 2009. All the patients eligible for the study consented to the
Translational Research Investigating Biomarker Endpoints in AKI
(TRIBE-AKI) protocol.10 The main inclusion criteria required cardiac sur-
gery with high risk for AKI defined by the presence of 1 or more of the
following: emergency surgery, preoperative serum creatinine greater than
2 mg/dL (>177 mmol/L), ejection fraction less than 35% or grade 3 or 4
left ventricular dysfunction, age greater than 70 years, diabetes mellitus,
concomitant CABG and valve surgery, or repeat revascularization sur-
gery.10,11 The cohort included patients undergoing off-pump coronary ar-
tery bypass and patients undergoing CPB. Patients with evidence of AKI
before surgery, prior kidney transplantation, preoperative serum creatinineThe Journal of Thoracic and Calevel greater than 4.5 mg/dL (>398 mmol/L), or end-stage renal disease
were excluded.
Sample Collection
Urine and plasma specimens were collected preoperatively, and the first
postoperative samples were collected soon after admission to the intensive
care unit. The remaining daily blood and urine samples were obtained at the
time of routine morning blood collection performed for clinical care.
Serum creatinine values were recorded for every patient throughout the
hospital stay. Further details on the sample collection and processing
have been described.10,11
Acute Kidney Injury Biomarker Measurements
Urinary NGAL (ng/mL) and IL-18 (pg/mL) were measured with the
ARCHITECT assay (Abbott Diagnostics, Abbott Park, Ill). Urine creati-
nine was measured by the modified Jaffe reaction. The intra-assay coeffi-
cient of variation for the urine creatinine assay was 5%, whereas the
coefficients of variations for the NGAL and IL-18 assays were approxi-
mately 5% and 8%, respectively.
Study Variables
Published studies suggest a significantly increased risk of AKI with
transfusion of more than 2 PRBC units.12-15 We therefore analyzed the
cohort by dividing into 3 groups as receiving no blood, 2 or less PRBC
units, and more than 2 PRBC units intraoperatively. The primary
outcome was the development of AKI, defined in 3 ways: (1) at least a
doubling in serum creatinine from the baseline preoperative value; (2)
urinary IL-18 concentration in the highest quintile; or (3) urinary NGAL
in the highest quintile. We limited our analysis to first postoperative
biomarker values because we have previously shown the association of
these values with AKI in cardiac surgery cases.10 Preoperative characteris-
tics, operative details, and postoperative complications were collected. For
postoperative complications, the definitions of the Society of Thoracic Sur-
geons database were used. The number of PRBC transfusions received in-
traoperatively was recorded for every patient. Cardiac catheterization if
received within 48 hours of index surgery was recorded. Preoperative esti-
mated glomerular filtration rate (eGFR) was estimated using the Chronic
Kidney Disease Epidemiology Collaboration equations.16 All preoperative
creatinine values were measured within 2 months before surgery.
Statistical Analysis
Patients’ baseline characteristics were compared across the 3 groups.
We analyzed categoric and continuous variables using chi-square andKrus-
kal–Wallis statistics, respectively. We assessed the outcome of severe AKI
on the basis of serum creatinine and biomarkers as described earlier. We
also examined the distribution of the urinary biomarkers across the 3
groups. We used the first postoperative values of urine biomarkers because
these have been demonstrated to be associated with AKI in our prior obser-
vations.10,17 Relative risk (RR) of severe AKI was calculated using Poisson
regression with robust error variance in the 2 groups who received 2 or less
PRBC units or more than 2 PRBC units, using the group with no blood
transfusion as reference. We adjusted for various important covariates
that are associated with AKI, including patient demographics (white
race, age, sex), clinical risk factors (preoperative eGFR, diabetes,
hypertension, congestive heart failure, cardiac catheterization in the last
48 hours), and operative characteristics (elective vs nonelective surgery,
CPB time and type of surgery [CABG, CABG and valve, valve]). To
minimize the indication bias that is associated with PRBC use, we also
used propensity scores as a covariate and weighted propensity scores to
calculate the RR. The RR was adjusted for propensity score, which
provides a way to summarize covariate information about group bias
(treatment selection) into a scalar value. The propensity score probability
was calculated from logistic regression after accounting for covariates
listed earlier, including PRBC groups.rdiovascular Surgery c Volume 148, Number 2 727
FIGURE 1. A, The direct effect of independent variable (X) on dependent
variable (Y) denoted as C. B, The effect of X on Y through a mediator (M)
where the association between X and M is denoted as ‘‘a’’, the association
between M and Y is denoted as ‘‘b’’, and the association of X and M to Y is
denoted as C, such that C ¼ C þ ab.
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MTo explore the association between blood transfusion and AKI further,
we sought to analyze the alternative pathways that can mediate this effect.
We conducted the mediation analysis to determine whether urine bio-
markers are an intermediate between red blood cell (RBC) use and the
development of AKI. To explore the mediation pathway, first the direct ef-
fect of independent variable X (PRBC) on dependent variable Y (AKI) was
calculated as ‘‘C’’. The association between X and M (biomarker) and M
and Y were calculated as ‘‘a’’ and ‘‘b’’, respectively. Assuming there is
mediation between X and Y through M, the residual direct effect of X on
Y was then calculated as ‘‘C’’ (Figure 1). The equation to calculate the ef-
fect of X on Y (ie, ‘‘C’’) then can be written as follows:
C ¼ Cþab
Provided ‘‘a’’, ‘‘b’’, and ‘‘C’’ remain significant, if C is nonzero but the
direct effect of X to Y (ie, ‘‘C’’) is decreased, then there is partial mediation
through a mediator pathway. If C is 0 (ie, the effect of X to Y disappears),
then the effect is mediated fully through alternative pathway M, which is a
biomarker in this case. We used the Sobel test18 to evaluate the mediation
analysis. The results were considered significant with a 2-sided a error less
than 0.05. All analyses were conducted in SAS version 9.2 (SAS Institute
Inc, Cary, NC).
RESULTS
Characteristics of the Study Cohort
A total of 1210 patients were included in this analysis
who underwent cardiac surgery in 6 university-affiliated
hospitals in North America. A comparison of baseline char-
acteristics between the patients who received no blood and
the patients who received 2 or less PRBC units or more than
2 PRBC units is presented in Table 1. The mean age of all
patients was 71 years. Overall, 68% of the patients were
male, 94% were white, and 42% had diabetes. A higher
proportion of patients who underwent nonelective surgery
or a combined procedure (CABG and valve) required
more than 2 PRBC units. Also, more patients who under-
went CABG with CPB required PRBC transfusion (28%)
as opposed to those who underwent off-pump coronary728 The Journal of Thoracic and Cardiovascular Surgartery bypass (15%). The mean eGFR was lower (57.2
mL/min/1.73 m2) in the patients requiring more than 2
PRBC units compared with those who did not require blood
(70.3 mL/min/1.73 m2).
Association of Packed Red Blood Cell Transfusion
With Acute Kidney Injury
The outcome of severe AKI defined by serum creatinine
or novel biomarkers was higher in patients who received
more than 2 PRBC units compared with those who did
not receive any blood or received 2 or less PRBC units
(Table 2). The first postoperative values of urinary IL-18
and urinary NGAL were significantly higher in patients
who received more than 2 PRBC units compared with those
who did not receive any blood or received 2 or less PRBC
units (Figure 2).
In patients receivingmore than 2 PRBCunits, the adjusted
RRs were 2.3 (95% confidence interval [CI], 1.2-4.4;
P<.01), 1.36 (95% CI, 1.0-1.9; P ¼ .05), and 1.34 (95%
CI, 0.98-1.8, P¼ .06) for doubling of serum creatinine, uri-
nary IL-18 in the fifth quintile (>60 pg/mL), and urinary
NGAL in the fifth quintile (>102 ng/mL), respectively
(Table 2). The results for doubling of serum creatinine
remained virtually unchanged when we adjusted for propen-
sity score to receive PRBC (RR, 2.3; 95% CI, 1.1-4.7).
Mediation Analysis
Mediation analysis revealed that 17% of the total effect
of transfusing greater than 2 PRBC units on doubling of
serum creatinine was mediated by IL-18. Mediation anal-
ysis for NGAL was not significant (Table 3).
DISCUSSION
The association between intraoperative blood transfusion
during cardiac surgery and AKI using serum creatinine has
been reported by prior studies.6,13-15,19 In our analyses, we
demonstrated that compared with patients who received no
or 2 or less units, receipt of more than 2 PRBC units was
significantly associated with the risk for AKI, as defined
not only by changes in serum creatinine but also by the
absolute concentrations of urinary biomarkers of kidney
injury (IL-18 and NGAL). This risk associated with
greater than 2 units of blood was not attenuated in the
propensity analysis models, which accounted for potential
treatment selection bias. In concordance with the animal
studies, we also demonstrated that some of the effect of
clinical AKI is mediated through the IL-18 pathway.
The association between blood transfusion and AKI may
be due to a direct transfusion-related kidney injury or an in-
direct effect in which the transfusion is acting as a surrogate
marker for hypotension or decreased oxygen delivery. The
pathophysiology of organ injury after blood transfusion is
not clearly understood, but there are many possible mecha-
nisms that likely play a role. It has been reported that RBCsery c August 2014
TABLE 1. Baseline characteristics of patients by number of units transfused
Characteristics All patients (n ¼ 1210) No blood (n ¼ 894) 1-2 PRBC (n ¼ 206) >2 PRBC (n ¼ 110) P value*
Preoperative factors
Age, y, mean (SD) 71 (10) 71 (10) 73 (11) 73 (11) <.0001
Male, n (%) 820 (86) 682 (76) 93 (45) 45 (41) <.0001
White, n (%) 1132 (94) 848 (95) 188 (91) 96 (87) .0032
Diabetes, n (%) 508 (42) 393 (44) 74 (36) 41 (37) .0626
Hypertension, n (%) 953 (79) 697 (78%) 165 (80%) 91 (83%) .45
Congestive heart failure, n (%) 312 (26) 195 (22%) 67 (33%) 50 (45%) <.0001
Cardiac catheterization in last 48 h, n (%) 72 (6) 41 (5%) 22 (11%) 9 (8%) <.01
Myocardial infarction, n (%) 310 (26) 241 (28%) 47 (24%) 22 (20%) .15
Preoperative eGFR, mean (SD) 68 (21) 70.33 (20.04) 66.05 (21.98) 57.18 (21.65) <.0001
Preoperative CKD stage <.0001
Stage 1, n (%) 164 (14) 131 (15%) 24 (12) 9 (8)
Stage 2, n (%) 612 (51) 478 (53) 99 (48) 35 (32)
Stage 3, n (%) 406 (34) 274 (31) 75 (36) 57 (52)
Stage 4, n (%) 28 (2) 11 (1) 8 (4) 9 (8)
Preoperative sCr, mean (SD) 1.09 (0.34) 1.08 (0.32) 1.07 (0.36) 1.23 (0.45) .0018
Preoperative medications
Aspirin 894 (74%) 679 (76%) 134 (65%) 81 (74%) .0
Beta-blockers 890 (74%) 665 (75%) 139 (68%) 86 (79%) .06
ACE inhibitors or ARB 552 (46%) 415 (47%) 92 (45%) 45 (41%) .54
Statins 894 (74%) 676 (76%) 143 (69%) 75 (69%) .07
Status of surgery <.0001
Elective, n (%) 956 (79) 738 (83) 150 (73) 68 (62)
Nonelective, n (%) 254 (21) 156 (17) 56 (27) 42 (38)
Intraoperative factors
OPCAB, n (%) 117 (10) 100 (11) 14 (7) 3 (3) .01
CPB time, (m) mean (SD) 114 (60) 106 (55) 125 (60) 160 (73) <.0001
Crossclamp time (min), mean (SD) 78 (44) 72 (41) 85 (47) 108 (52) <.0001
Cardioplegia, n (%) 1068 (88) 779 (87%) 185 (90%) 104 (95%) .06
No. of PRBC units transfused, mean (SD) 0.69 (1.57) 0 (0) 1.6 (0.49) 4.59 (2.45) <.0001
Type of surgery <.0001
CABG, n (%) 580 (48) 482 (54) 74 (36) 24 (22)
CABG and valve, n (%) 277 (23) 176 (20) 54 (26) 47 (43)
Valve, n (%) 353 (29) 236 (26) 78 (38) 39 (35)
Intra-aortic balloon pump, n (%) 56 (3) 31 (3%) 11 (5%) 14 (13%) <.0001
Peak sCr is defined as the peak postoperative creatinine minus the preoperative serum creatinine value. ACE, Angiotensin-converting enzyme; ARB, angiotensin receptor blocker;
CABG, coronary artery bypass grafting; CKD, chronic kidney disease; CPB, cardiopulmonary bypass; eGFR, estimated glomerular filtration rate; OPCAB, off-pump coronary
artery bypass; PRBC, packed red blood cell; sCr, serum creatinine; SD, standard deviation. *P values were calculated using Kruskal–Wallis test for continuous variables and chi-
square test for categoric variables.
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Mpreserved under hypothermic conditions undergo a series
of changes that affect their viability and functionality
post-transfusion. Stored RBCs become adenosine triphos-
phate and 2,3-diphosphoglycerate depleted,20 which
causes cell membrane oxidative stress, resulting in
cytoskeleton changes and decreased deformability.21-25
Current guidelines for blood preservation promote newer
preservatives that can attenuate these metabolic effects,
prolonging the stored time period to 42 days. However,
these cell membrane processes are not completely halted.
Berezina and colleagues22 concluded that stored RBCs
can undergo significant irreversible changes and develop
hemolysis during the second week of preservation long
before the expiration currently set by blood banks.22 This
finding has important clinical implications. In a study inThe Journal of Thoracic and Cawhich the complications after cardiac surgery were corre-
lated with the age of stored blood, authors found that pa-
tients who received blood older than 14 days had a higher
incidence of AKI (2.7% vs 1.6%).19 Depletion of RBC
2,3-diphosphoglycerate also shifts the oxygen dissociation
curve to the left, perpetuating ischemic injury. Increased
platelet activation and thrombogenesis by altered cell mem-
branes of stored RBCs also has been shown to be another
possible mechanism of organ injury after blood transfu-
sion.23 Hemolysis of stored blood also results in release
of free hemoglobin and iron in the supernatant.24-26
Transfusion of 2 units of PRBC may result in elevation of
free plasma hemoglobin by approximately 10-fold above
the normal limits.27 The free hemoglobin and iron can cause
toxic injury to the tubules and lead to AKI.rdiovascular Surgery c Volume 148, Number 2 729
TABLE 2. Association of blood transfusion with acute kidney injury assessed with serum creatinine and urine biomarkers of kidney injury
Doubling of serum creatinine Urine IL-18>60 pg/mLz Urine NGAL>102 ng/mLz
n (%)
Unadjusted
RR (95% CI)
Adjusted RRy
(95% CI) n (%)
Unadjusted
RR (95% CI)
Adjusted RRy
(95% CI) n (%)
Unadjusted RR
(95% CI)
Adjusted RRy
(95% CI)
No blood
(n ¼ 894)
30 (3) 1.0 (referent) 1.0 (referent) 150 (17) 1.0 (referent) 1.0 (referent) 146 (16) 1.0 (referent) 1.0 (referent)
1-2 PRBC
(n ¼ 206)
9 (4) 1.30 (0.63-2.7) 1.06 (0.52-2.2) 44 (22) 1.30 (0.96-1.75) 1.02 (0.75-1.39) 44 (22) 1.33 (0.99-1.8) 0.98 (0.72-1.34)
>2 PRBC
(n ¼ 110)
19 (17) 5.15 (3-8.83) 2.29 (1.21-4.4) 42 (40) 2.34 (1.77-3.08) 1.36 (1-1.85) 46 (43) 2.63 (2.02-3.42) 1.34 (0.98-1.84)
P value* <.0001 — .01 .02 — .05 .02 — .06
CI, Confidence interval; IL, interleukin; NGAL, neutrophil gelatinase-associated lipocalin; PRBC, packed red blood cell; RR, relative risk. *P values were calculated using chi-
square test. yAdjusted for race, sex, age, preoperative eGFR, diabetes, hypertension, congestive heart failure, myocardial infarction, cardiac catheterization within 48 hours, status
of surgery (elective vs nonelective), type of surgery (CABG, valve, or both), and perfusion time. zIL-18>60 pg/mL and NGAL>102 ng/mL represent the fifth quintile of the first
postoperative biomarker values in the cardiac surgery cohort.
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P
MIt is possible that blood transfusion is simply a marker for
higher-risk patients who are more susceptible to AKI
because of low baseline HCT or a lower intraoperative
HCT. Huybregts and colleagues13 analyzed the association
of low HCT and PRBC transfusion with AKI using
N-acetyl-ß-D-glucosaminidase as a marker of kidney
injury.13 The authors found that the levels of N-acetyl-
ß-D-glucosaminidase were relatively higher among patients
who had received 2 or more PRBC units when comparedFIGURE 2. Distribution of urinary biomarkers in different groups by
blood transfusion is shown in box plot. The bars represent the interquartile
range, and the solid lines in the bars represent the median values of first
postoperative urinary IL-18 and urinary NGAL. The median values of
both urinary IL-18 and urinary NGAL were significantly elevated in those
who received more than 2 PRBC units compared with those who received
less than 2 PRBC units (P values for Wilcoxon test<.0001 and<.0001,
respectively) or no blood (P values for Wilcoxon test <.0001 and
<.0001, respectively). *No blood versus more than 2 PRBC, P<.0001.
^Less than 2 PRBC versus more than 2 PRBC, P<.0001. IL, Interleukin;
NGAL, neutrophil gelatinase-associated lipocalin; PRBC, packed red blood
cell.
730 The Journal of Thoracic and Cardiovascular Surgwith the group with HCT less than 24%, suggesting that
transfusion of blood may have had some role in causing
AKI in addition to low HCT. Other studies also have shown
a synergistic effect of blood transfusion to perioperative
anemia in increasing the risk of AKI while both factors
were independently associated with AKI.24,28
It is noteworthy that we also did not observe an increase
in risk of severe AKI with blood transfusion of up to 2
PRBC units. This observation has potentially important
clinical implications. Tolerance of permissive anemia is
important because perioperative blood conservation strate-
gies are evolving and shown to be effective and associated
with better outcomes.29,30 However, it is well known that
excessively low HCT can be associated with postoperative
AKI.31,32 Thus, our observations suggest that judicious
transfusion of PRBC up to 2 units may be safe and
prevent postoperative AKI. It is important to note that
although poor organ perfusion is a cause of organ
dysfunction in critically ill patients, HCT is a poor
surrogate of oxygen delivery. The evidence is currently
lacking that increasing HCT would necessarily lead to
improved perfusion.33
Our examination of the expression of kidney injury bio-
markers in response to blood transfusion is unique
compared with previous data. IL-18 is a proinflammatory
biomarker and causes increased apoptosis in the proximal
tubular cells. IL-18 is activated from its pro-form by the
caspase-1 pathway in response to several stressors, such
as ischemia, nephrotoxins, or reperfusion.9 Moreover,
IL-18 itself may be injurious to tissues and thus not only
a biomarker but also a mediator of AKI through a
caspase-1 and NLRP3 inflammasome-mediated apoptosis.9
Several studies in experimental animals have demonstrated
that IL-18–neutralizing antibodies can reduce the amount of
tissue injury. The mediation analysis we performed sup-
ports the notion that IL-18 expression may be exacerbating
clinical AKI. Thus, this approach may be used as a model to
identify other potential biomarker-modifiers, which may
offer therapeutic targets to reduce AKI.ery c August 2014
TABLE 3. Mediation analysis to evaluate indirect effect of packed red blood cells on acute kidney injury via biomarkers
Direct pathway
estimate C
Alternate pathway estimate Mediation
estimate C
Sobel
test
Mediation
percentage
P value for
mediationa b
Urine IL-18 (pg/mL) 0.973 0.518 0.32 0.822 2.19 17.07% .02
Urine NGAL (ng/mL) 0.973 0.496 0.122 0.901 1.3 6.22% .19
Mediation percentage is the percentage of total effect of PRBC transfusion on AKI that is mediated via biomarkers. IL, Interleukin; NGAL, neutrophil gelatinase-associated
lipocalin.
Khan et al Perioperative ManagementStudy Limitations
Amajor limitation in our study was that preoperative and
perioperative HCT values were not collected in the original
TRIBE-AKI protocol. However, prior studies have demon-
strated that the lowest HCT during CPB is highly associated
with peak fractional change in serum creatinine and the
highest postoperative creatinine value.32 We also did not
control transfusion triggers; we have simply reported the
current intraoperative practices as they pertain to the insti-
tutions participating in this study. The dialysis events
were low, and thus we could not study this group separately.
This study also is observational in nature and thus limits our
ability to confirm any potential causal association between
PRBC and AKI outcomes. Although we attempted to ac-
count for differences in exposures, patients who required
more PRBC transfusions may have had a greater severity
of illness or intraoperative complications. We also did not
collect the age of PRBC units transfused to our patients,
which may affect the outcomes of AKI as discussed earlier.MCONCLUSIONS
Blood transfusion of more than 2 units is independently
associated with AKI defined by both serum creatinine and
urinary biomarkers of kidney injury in the setting of cardiac
surgery. These findings provide additional evidence that
may be used to design interventions that can alleviate kid-
ney injury associated with blood transfusion. A major clin-
ical implication of our study is that blood transfusion should
be used judiciously in selected patients with a careful
assessment of risk–benefit ratio.
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